Joseph Hardie

1.5k total citations
27 papers, 1.3k citations indexed

About

Joseph Hardie is a scholar working on Molecular Biology, Biomedical Engineering and Immunology. According to data from OpenAlex, Joseph Hardie has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Biomedical Engineering and 5 papers in Immunology. Recurrent topics in Joseph Hardie's work include Advanced biosensing and bioanalysis techniques (9 papers), RNA Interference and Gene Delivery (8 papers) and Nanoparticle-Based Drug Delivery (4 papers). Joseph Hardie is often cited by papers focused on Advanced biosensing and bioanalysis techniques (9 papers), RNA Interference and Gene Delivery (8 papers) and Nanoparticle-Based Drug Delivery (4 papers). Joseph Hardie collaborates with scholars based in United States, China and South Korea. Joseph Hardie's co-authors include Vincent M. Rotello, Michelle E. Farkas, Yuanchang Liu, Xianzhi Zhang, Rui Tang, Moumita Ray, Yi-Wei Lee, David C. Luther, Federica Scaletti and Ying Jiang and has published in prestigious journals such as Chemical Society Reviews, ACS Nano and Analytical Chemistry.

In The Last Decade

Joseph Hardie

27 papers receiving 1.2k citations

Peers

Countries citing papers authored by Joseph Hardie

Since Specialization

Citations

This map shows the geographic impact of Joseph Hardie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Hardie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Hardie more than expected).

Fields of papers citing papers by Joseph Hardie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Hardie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Hardie. The network helps show where Joseph Hardie may publish in the future.

Co-authorship network of co-authors of Joseph Hardie

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Hardie. A scholar is included among the top collaborators of Joseph Hardie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Hardie. Joseph Hardie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Automated, Deep Learning‐Enabled Immunoassay Microfluidic Cartridge for Viral Pathogen Detection 2025 ·Advanced Materials Technologies ·Joseph Hardie, Sungwan Kim, Zhimin Yin, (unknown), (unknown), Jane J. Kim, (unknown), Prudhvi Thirumalaraju, Manoj Kumar Kanakasabapathy, (unknown), (unknown), (unknown), (unknown), (unknown), E. Weinmann, Daniel R. Kuritzkes, (unknown), Raymond T. Chung, Jorge Mera, Hadi Shafiee	1
2	Deactivated Cas9-Engineered Magnetic Micromotors toward a Point-of-Care Digital Viral RNA Assay 2025 ·ACS Nano ·Younseong Song, (unknown), Prudhvi Thirumalaraju, (unknown), Joseph Hardie, Arafeh Bigdeli, Yingnan Bai, (unknown), Jungmin Yoo, Manoj Kumar Kanakasabapathy, Sungwan Kim, (unknown), Hui Chen, Jonathan Z. Li, Athe Tsibris, (unknown), Hadi Shafiee	4
3	Ultrasensitive and long-lasting bioluminescence immunoassay for point-of-care viral antigen detection 2025 ·Nature Biomedical Engineering ·Sungwan Kim, (unknown), (unknown), (unknown), (unknown), Jane J. Kim, (unknown), Joseph Hardie, Manoj Kumar Kanakasabapathy, Hemanth Kandula, Prudhvi Thirumalaraju, Younseong Song, Hui Chen, (unknown), Jonathan Z. Li, Athe Tsibris, Hadi Shafiee	3
4	Long‐Lasting, Transparent Antibacterial Shield: A Durable, Broad‐Spectrum Anti‐Bacterial, Non‐Cytotoxic, Transparent Nanocoating for Extended Wear Contact Lenses (Small 11/2025) 2025 ·Small ·(unknown), (unknown), Younseong Song, (unknown), (unknown), Sunghyun Yoon, (unknown), (unknown), (unknown), Joseph Hardie, (unknown), Kyoung G. Lee, Yong Woo Ji, Sung Gap Im	1
5	Long‐Lasting, Transparent Antibacterial Shield: A Durable, Broad‐Spectrum Anti‐Bacterial, Non‐Cytotoxic, Transparent Nanocoating for Extended Wear Contact Lenses 2024 ·Small ·(unknown), (unknown), Younseong Song, (unknown), (unknown), Sunghyun Yoon, (unknown), (unknown), (unknown), Joseph Hardie, (unknown), Kyoung G. Lee, Yong Woo Ji, Sung Gap Im	3
6	Deep learning-assisted sensitive detection of fentanyl using a bubbling-microchip 2022 ·Lab on a Chip ·Hui Chen, Sungwan Kim, Joseph Hardie, Prudhvi Thirumalaraju, (unknown), (unknown), (unknown), (unknown), (unknown), Manoj Kumar Kanakasabapathy, Hadi Shafiee	6
7	Could artificial intelligence revolutionize the development of nanovectors for gene therapy and mRNA vaccines? 2022 ·Nano Today ·Akbar Hasanzadeh, Michael R. Hamblin, Jafar Kiani, (unknown), Joseph Hardie, Mahdi Karimi, Hadi Shafiee	42
8	Selective treatment of intracellular bacterial infections using host cell-targeted bioorthogonal nanozymes 2022 ·Materials Horizons ·Joseph Hardie, Jessa Marie Makabenta, Aarohi Gupta, Rui Huang, Roberto Cao‐Milán, Ritabrita Goswami, Xianzhi Zhang, (unknown), Michelle E. Farkas, Vincent M. Rotello	39
9	SARS‐CoV‐2 RNA Detection by a Cellphone‐Based Amplification‐Free System with CRISPR/CAS‐Dependent Enzymatic (CASCADE) Assay 2021 ·Advanced Materials Technologies ·(unknown), (unknown), (unknown), Hemanth Kandula, Prudhvi Thirumalaraju, Manoj Kumar Kanakasabapathy, Joseph Hardie, Luis G. C. Pacheco, Jonathan Z. Li, Daniel R. Kuritzkes, Hadi Shafiee	52
10	CHEMICAL MANIPULATION OF MACROPHAGES: NANOMATERIAL AND MOLECULAR APPROACHES 2021 ·Scholarworks (University of Massachusetts Amherst) ·Joseph Hardie	1
11	Macrophage activation by a substituted pyrimido[5,4-b]indole increases anti-cancer activity 2019 ·Pharmacological Research ·Joseph Hardie, (unknown), Siyoung Ha, (unknown), Michelle E. Farkas	16
12	Nanocapsule-mediated cytosolic siRNA delivery for anti-inflammatory treatment 2018 ·Journal of Controlled Release ·Ying Jiang, Joseph Hardie, Yuanchang Liu, Moumita Ray, Xiang Luo, Riddha Das, Ryan F. Landis, Michelle E. Farkas, Vincent M. Rotello	32
13	Protein delivery into cells using inorganic nanoparticle–protein supramolecular assemblies 2018 ·Chemical Society Reviews ·Federica Scaletti, Joseph Hardie, Yi-Wei Lee, David C. Luther, Moumita Ray, Vincent M. Rotello	177
14	CRISPRed Macrophages for Cell-Based Cancer Immunotherapy 2018 ·Bioconjugate Chemistry ·Moumita Ray, Yi-Wei Lee, Joseph Hardie, Rubul Mout, Gülen Yesilbag Tonga, Michelle E. Farkas, Vincent M. Rotello	95
15	Surface-Modified Macrophages Facilitate Tracking of Breast Cancer-Immune Interactions 2018 ·ACS Chemical Biology ·Bishnu Prasad Joshi, Joseph Hardie, (unknown), Michelle E. Farkas	16
16	Effects of engineered nanoparticles on the innate immune system 2017 ·Seminars in Immunology ·Yuanchang Liu, Joseph Hardie, Xianzhi Zhang, Vincent M. Rotello	235
17	Progress and perspective of inorganic nanoparticle-based siRNA delivery systems 2016 ·Expert Opinion on Drug Delivery ·Ying Jiang, Shuaidong Huo, Joseph Hardie, Xing‐Jie Liang, Vincent M. Rotello	91
18	Chemically Engineered Nanoparticle–Protein Interface for Real‐Time Cellular Oxidative Stress Monitoring 2016 ·Small ·Ying Jiang, Ming Wang, Joseph Hardie, Gülen Yesilbag Tonga, Moumita Ray, Qiaobing Xu, Vincent M. Rotello	19
19	Promises and Pitfalls of Intracellular Delivery of Proteins 2014 ·Bioconjugate Chemistry ·(unknown), Rui Tang, Joseph Hardie, Michelle E. Farkas, Vincent M. Rotello	278
20	(1H-Imidazol-4-yl)methanol 2013 ·Acta Crystallographica Section E Structure Reports Online ·(unknown), (unknown), Joseph Hardie, Benny C. Chan	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact